CVRx Stock (NASDAQ:CVRX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$14.07

52W Range

$6.40 - $33.13

50D Avg

$8.93

200D Avg

$13.33

Market Cap

$285.83M

Avg Vol (3M)

$311.97K

Beta

1.21

Div Yield

-

CVRX Company Profile


CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

200

IPO Date

Jun 30, 2021

Website

CVRX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
U.S.$35.11M$18.02M$9.15M
Germany$3.69M$3.48M$3.25M
Other countries$494.00K$971.00K$639.00K

Fiscal year ends in Dec 23 | Currency in USD

CVRX Financial Summary


Dec 23Dec 22Dec 21
Revenue$39.30M$22.47M$13.04M
Operating Income$-43.10M$-42.53M$-25.97M
Net Income$-41.20M$-41.43M$-43.08M
EBITDA$-43.10M$-41.15M$-40.77M
Basic EPS-$-2.02$-4.16
Diluted EPS-$-2.02$-4.16

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 29, 24 | 10:38 PM
Q2 24Jul 29, 24 | 7:56 PM
Q1 24Apr 30, 24 | 12:00 AM

Peer Comparison


TickerCompany
ANIKAnika Therapeutics, Inc.
OFIXOrthofix Medical Inc.
SGHTSight Sciences, Inc.
LUNGPulmonx Corporation
NPCENeuroPace, Inc.
AXDXAccelerate Diagnostics, Inc.
SRDXSurmodics, Inc.
LIVNLivaNova PLC
KIDSOrthoPediatrics Corp.
OSAProSomnus, Inc. Common Stock
AORTArtivion, Inc.
AXGNAxoGen, Inc.